Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions
Year: 2018
Type: review
Abstract: Patients with liver cirrhosis are susceptible to infections due to various mechanisms, including abnormalities of humoral and cell-mediated immunity and occurrence of bacterial translocation from the intestine.Bacterial infections are common and represent a reason for progression to liver failure and increased mortality.Fungal infections, mainly caused by Candida spp., are often associated to delayed diagnosis and high mortality rates.High level of suspicion along with prompt diagnosis and treatment of infections are warranted.Bacterial and fungal infections negatively affect the outcomes of liver transplant candidates and recipients, causing disease progression among patients on the waiting list and increasing mortality, especially in the early posttransplant period.Abdominal, biliary tract, and bloodstream infections caused by Gram-negative bacteria [e.g., Enterobacteriaceae and Pseudomonas aeruginosa (P.aeruginosa )] and Staphylococcus spp.are commonly encountered in liver transplant recipients.Due to frequent exposure to broad-spectrum antibiotics, invasive procedures, and prolonged hospitalizations, these patients are especially at risk of developing infections caused by multidrug resistant bacteria.The increase in antimicrobial resistance hampers the choice of an adequate empiric therapy and warrants the knowledge of the local microbial epidemiology and the implementation of infection control measures.The main characteristics and the management of bacterial and fungal infections in patients with liver cirrhosis and liver transplant recipients are presented.
Author: Elda Righi
Institution: Ospedale Santa Maria della Misericordia di Udine
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W2896472488